Literature DB >> 2112372

[A comparative study of UFT enteric-coated granules with UFT capsules on the occurrence of side effects in patients with head and neck cancers--a special attention to the upper gastrointestinal tract disorders].

M Ohyama1, M Matsumura, K Katsuta, T Nobori, H Matsuyama, K Fukami, R Kiyota, H Yano, T Shima, K Ogawa.   

Abstract

A comparative study on the occurrence of gastrointestinal side effects between UFT enteric-coated granules (UE) and UFT capsules (UC) was made by crossover method in 50 patients with head and neck cancer who were treated by these drugs as a surgical and/or radiation adjuvant chemotherapy. UE was significantly low in the occurrence of upper gastrointestinal side effects; remarkably low in such side effects as nausea and vomiting, in particular. On the other hand, there was little difference between UE and UC in the occurrence of such side effects as diarrhea, stomatitis, dry mouth and hematotoxic signs. The present result suggests that UE is clinically useful for treating the patients with cancer, with less occurrence of gastrointestinal side effects.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2112372

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  2 in total

1.  Complete response of highly advanced colon cancer with multiple lymph node metastases to irinotecan combined with UFT: report of a case.

Authors:  Yujiro Fujie; Masataka Ikeda; Iwao Seshimo; Koji Ezumi; Taishi Hata; Tatsushi Shingai; Masayoshi Yasui; Osamu Takayama; Hiroki Fukunaga; Masakazu Ikenaga; Ichiro Takemasa; Hirofumi Yamamoto; Masayuki Ohue; Mitsugu Sekimoto; Seiichi Hirota; Morito Monden
Journal:  Surg Today       Date:  2006-12-25       Impact factor: 2.549

Review 2.  Chemotherapy with enteric-coated tegafur/uracil for advanced hepatocellular carcinoma.

Authors:  Toru Ishikawa
Journal:  World J Gastroenterol       Date:  2008-05-14       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.